Month: September 2021

Ivermectin is a wondrous, Nobel Prize-winning drug that is cheap and available around the world.   The oral version — originally derived from a clump of Japanese dirt in the 1970s — has nearly eradicated infections that could otherwise have caused widespread blindness and disfigured people's limbs and genitals. Formulated as a lotion, ivermectin is safe enough to be administered as an over-the-counter treatment for head lice in kids. But ivermectin is not a miracle cure for COVID-19, and there's no reason to think it could or should ever be treated as such. Yet two men want you to think that ivermectin could be all we need to treat, or even prevent, any COVID-19 case: Dr. Pierre Kory, a former cr...

COLLEGE PARK, Md. — Recent COVID-19 variants are much more adept at airborne transmission than the original version of the coronavirus, according to a new study. University of Maryland researchers analyzed the Alpha variant originating out of the United Kingdom and discovered that carriers breathe out 43 to 100 times more infectious viral aerosols than those infected with the original strain. On a positive note, study authors say certain face coverings usually cut the amount of exhaled viral particles in half. “Our latest study provides further evidence of the importance of airborne transmission,” says Dr. Don Milton, professor of environmental health at Maryland’s School of Public Health (UMD SPH), in a university release. “We know that the Delta variant circulating now is even more ...

Sorry, Readability was unable to parse this page for content.

U.S. President Joe Biden departs after delivering an update on his administration's coronavirus disease (COVID-19) response in the Eisenhower Executive Office Building's South Court Auditorium at the White House in Washington, June 2, 2021. Carlos Barria | Reuters A key part of President Joe Biden's plan to combat Covid-19 is in jeopardy as a Food and Drug Administration vaccine advisory committee meets Friday to debate and vote on Pfizer and BioNTech's application to offer booster shots to the general public. The vote by the agency's Vaccines and Related Biological Products Advisory Committee — scheduled for around 2:30 p.m. ET — comes as some scientists, including at least two at the FDA, say they aren't entirely convinced every American who has received the Pf...